eFFECTOR Therapeutics, Inc. - FORM S-1 - EX-23.1 - December 18, 2020

Attached files

file filename
EX-99.6 - EX-99.6 - eFFECTOR Therapeutics, Inc.ck0001828522-ex996_52.htm
EX-99.5 - EX-99.5 - eFFECTOR Therapeutics, Inc.ck0001828522-ex995_53.htm
EX-99.4 - EX-99.4 - eFFECTOR Therapeutics, Inc.ck0001828522-ex994_51.htm
EX-99.3 - EX-99.3 - eFFECTOR Therapeutics, Inc.ck0001828522-ex993_50.htm
EX-99.2 - EX-99.2 - eFFECTOR Therapeutics, Inc.ck0001828522-ex992_202.htm
EX-99.1 - EX-99.1 - eFFECTOR Therapeutics, Inc.ck0001828522-ex991_201.htm
EX-14.1 - EX-14.1 - eFFECTOR Therapeutics, Inc.ck0001828522-ex141_200.htm
EX-10.7 - EX-10.7 - eFFECTOR Therapeutics, Inc.ck0001828522-ex107_199.htm
EX-10.6(B) - EX-10.6(B) - eFFECTOR Therapeutics, Inc.ck0001828522-ex106b_198.htm
EX-10.6(A) - EX-10.6(A) - eFFECTOR Therapeutics, Inc.ck0001828522-ex106a_318.htm
EX-10.5 - EX-10.5 - eFFECTOR Therapeutics, Inc.ck0001828522-ex105_197.htm
EX-10.4 - EX-10.4 - eFFECTOR Therapeutics, Inc.ck0001828522-ex104_196.htm
EX-10.3 - EX-10.3 - eFFECTOR Therapeutics, Inc.ck0001828522-ex103_195.htm
EX-10.2 - EX-10.2 - eFFECTOR Therapeutics, Inc.ck0001828522-ex102_193.htm
EX-10.1 - EX-10.1 - eFFECTOR Therapeutics, Inc.ck0001828522-ex101_194.htm
EX-5.1 - EX-5.1 - eFFECTOR Therapeutics, Inc.ck0001828522-ex51_205.htm
EX-4.4 - EX-4.4 - eFFECTOR Therapeutics, Inc.ck0001828522-ex44_206.htm
EX-4.2 - EX-4.2 - eFFECTOR Therapeutics, Inc.ck0001828522-ex42_204.htm
EX-4.1 - EX-4.1 - eFFECTOR Therapeutics, Inc.ck0001828522-ex41_203.htm
EX-3.2(B) - EX-3.2(B) - eFFECTOR Therapeutics, Inc.ck0001828522-ex32b_192.htm
EX-3.2(A) - EX-3.2(A) - eFFECTOR Therapeutics, Inc.ck0001828522-ex32a_48.htm
EX-3.1(B) - EX-3.1(B) - eFFECTOR Therapeutics, Inc.ck0001828522-ex31b_191.htm
EX-3.1(A) - EX-3.1(A) - eFFECTOR Therapeutics, Inc.ck0001828522-ex31a_49.htm
EX-1.1 - EX-1.1 - eFFECTOR Therapeutics, Inc.ck0001828522-ex11_317.htm
S-1 - S-1 - eFFECTOR Therapeutics, Inc.ck0001828522-s1.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the use in the Prospectus constituting a part of this Registration Statement on Form S-1 of our report dated December 18, 2020, relating to the financial statements of Locust Walk Acquisition Corp., which is contained in that Prospectus. We also consent to the reference to us under the caption “Experts” in the Prospectus.

 

/s/ WithumSmith+Brown, PC

 

 

 

 

 

New York, New York

 

 

December 18, 2020